X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2385) 2385
Publication (209) 209
Book Chapter (48) 48
Book Review (45) 45
Dissertation (11) 11
Conference Proceeding (3) 3
Newspaper Article (3) 3
Data Set (2) 2
Book / eBook (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1560) 1560
index medicus (1159) 1159
pharmacology & pharmacy (1094) 1094
cytochrome p450 (986) 986
metabolism (685) 685
male (564) 564
cytochrome p-450 cyp2d6 - genetics (525) 525
female (515) 515
cytochrome p-450 (492) 492
cyp2d6 (469) 469
pharmacogenetics (464) 464
cytochrome-p450 2d6 (461) 461
pharmacokinetics (449) 449
animals (448) 448
enzymes (429) 429
cytochrome p-450 enzyme system - metabolism (421) 421
genotype (404) 404
adult (390) 390
cytochrome p-450 cyp2d6 - metabolism (345) 345
middle aged (342) 342
drug interactions (309) 309
cytochrome (303) 303
polymorphism (294) 294
toxicology (294) 294
biochemistry & molecular biology (274) 274
drug metabolism (256) 256
in-vitro (254) 254
metabolites (242) 242
phenotype (237) 237
research (235) 235
human liver-microsomes (221) 221
physiological aspects (221) 221
aged (219) 219
cytochrome p-450 enzyme system - genetics (215) 215
inhibition (210) 210
liver (209) 209
cyp2d6 protein (205) 205
analysis (202) 202
genetic aspects (200) 200
pharmacology (200) 200
polymorphism, genetic (196) 196
cytochromes p450 (192) 192
alleles (190) 190
drugs (181) 181
genetic polymorphisms (178) 178
cytochrome p450 2d6 (175) 175
hydroxylation (158) 158
psychiatry (151) 151
rats (150) 150
microsomes, liver - metabolism (141) 141
biotransformation (139) 139
kinetics (139) 139
medicine (138) 138
microsomes, liver - enzymology (138) 138
cytochrome p-450 enzyme inhibitors (134) 134
article (131) 131
chemistry, medicinal (130) 130
expression (130) 130
cancer (126) 126
cytochrome-p450 (126) 126
drug-metabolism (126) 126
health aspects (125) 125
population (125) 125
adolescent (121) 121
young adult (120) 120
antidepressants (116) 116
human cytochrome-p450 2d6 (116) 116
research article (116) 116
dose-response relationship, drug (115) 115
pharmacogenomics (115) 115
microsomes (114) 114
polymorphisms (113) 113
tamoxifen (113) 113
drug therapy (110) 110
microsomes, liver - drug effects (107) 107
oxidation (107) 107
genes (106) 106
chemistry, multidisciplinary (105) 105
oncology (105) 105
pharmaceutical preparations - metabolism (105) 105
enzyme inhibitors - pharmacology (104) 104
gene frequency (104) 104
debrisoquine (103) 103
genetics & heredity (102) 102
cytochrome p-450 cyp2d6 inhibitors (100) 100
mice (100) 100
p-glycoprotein (100) 100
drug-drug interactions (99) 99
toxicity (97) 97
multidisciplinary sciences (95) 95
substrate specificity (95) 95
2d6 (94) 94
p450 (92) 92
treatment outcome (92) 92
cytochrome-p450 enzymes (91) 91
identification (91) 91
neurosciences (91) 91
mass spectrometry (90) 90
proteins (90) 90
chromatography, high pressure liquid (88) 88
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2380) 2380
Japanese (19) 19
German (17) 17
French (8) 8
Spanish (7) 7
Chinese (5) 5
Korean (3) 3
Russian (3) 3
Polish (2) 2
Turkish (2) 2
Czech (1) 1
Dutch (1) 1
Italian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Biological Chemistry, ISSN 0021-9258, 02/2013, Volume 288, Issue 6, pp. 4436 - 4451
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 03/2012, Volume 287, Issue 14, pp. 10834 - 10843
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 1/2007, Volume 101, Issue 1, pp. 113 - 121
Journal Article
Journal Article
Journal Article
Journal Article
Pharmcoepidemiology and Drug Safety, ISSN 1053-8569, 07/2017, Volume 26, Issue 7, pp. 752 - 765
Purpose: Metoprolol and paroxetine/fluoxetine are inevitably co-prescribed because cardiovascular disorders and depression often coexist in the elderly. This... 
CYP2D6 | metoprolol | cytochrome P450 (CYP)‐based drug–drug interactions (DDI) | beta‐blockers | paroxetine/fluoxetine | antidepressants | pharmacoepidemiology | cytochrome P450 (CYP)-based drug–drug interactions (DDI) | beta-blockers | DEPRESSION | INTERACTION ALERTS | HEART-FAILURE | RELEASE | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | paroxetine | fluoxetine | PHARMACOKINETICS | PRESCRIPTION | ACUTE MYOCARDIAL-INFARCTION | CARDIOVASCULAR-DISEASE | PHARMACOLOGY & PHARMACY | cytochrome P450 (CYP)-based drug-drug interactions (DDI) | ENZYME-INHIBITOR | Paroxetine - pharmacokinetics | Serotonin Uptake Inhibitors - pharmacokinetics | Fluoxetine - pharmacokinetics | Humans | Middle Aged | Serotonin Uptake Inhibitors - therapeutic use | Male | Metoprolol - therapeutic use | Metoprolol - administration & dosage | Paroxetine - therapeutic use | Anti-Arrhythmia Agents - therapeutic use | Anti-Arrhythmia Agents - pharmacokinetics | Anti-Arrhythmia Agents - administration & dosage | Paroxetine - administration & dosage | Metoprolol - pharmacokinetics | Drug Interactions | Serotonin Uptake Inhibitors - administration & dosage | Fluoxetine - administration & dosage | Cytochrome P-450 CYP2D6 - metabolism | Female | Aged | Fluoxetine - therapeutic use | Elderly people | Cytochrome | Drugs | Therapy | Paroxetine | Metoprolol | Fluoxetine | Cytochrome P450 | Drug interactions | Disorders | Dispensing | Mental depression | Patients | Computer programs | Signaling | Antidepressants | Older people | Software | Drug interaction | Elderly | CYP2D6 protein | Geriatrics
Journal Article
Biotechnology Journal, ISSN 1860-6768, 11/2012, Volume 7, Issue 11, pp. 1346 - 1358
Journal Article